Insider Trading & Ownership - ALTSCHULLER Susan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ALTSCHULLER Susan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-14
Purchase
2024-08-15
4:15 pm
Mural Oncology plc MURA ALTSCHULLER Susan
Director
10,000 $3.2071 $32,071 10,000
(Direct)
View
2024-08-01
Sale
2024-08-05
4:26 pm
Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer
16,913 $0 $0 0
(Direct)
View
2023-12-20
Sale
2023-12-21
8:12 pm
Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer
13,808 $41.42 $571,972 16,913
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-30
Option Award(A)
2024-06-05
4:08 pm
N/A
2034-05-29
Mural Oncology plc MURA ALTSCHULLER Susan
Director
8,462 $0 8,462
(Direct)
View
2024-05-30
Option Award
2024-06-03
10:11 am
N/A
2034-05-29
Mural Oncology plc MURA ALTSCHULLER Susan
Director
8,462 $3.35 8,462
(Direct)
View
2024-01-19
Option Award
2024-01-23
5:51 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer
81,065 $0 81,065
(Direct)
View
2023-12-19
Exercise
2023-12-21
8:12 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer
30,721 $0 16,913
(Direct)
View
2023-12-14
Option Award
2023-12-18
4:30 pm
N/A
2033-12-13
Mural Oncology plc MURA ALTSCHULLER Susan
Director
15,021 $0 15,021
(Direct)
View
2023-06-01
Option Award
2023-06-05
8:15 pm
N/A
2033-06-01
Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer
154,889 $0 154,889
(Direct)
View
2022-05-20
Option Award
2022-12-27
5:14 pm
2022-05-20
2030-07-20
ImmunoGen Inc. IMGN ALTSCHULLER Susan
SVP AND CFO
123,750 $0 165,000
(Direct)
View
2022-02-04
Option Award
2022-02-08
5:27 pm
2023-02-04
2032-02-04
ImmunoGen Inc. IMGN ALTSCHULLER Susan
SVP & Chief Financial Officer
361,568 $5.32 361,568
(Direct)
View
2021-02-05
Option Award
2021-02-09
8:11 pm
2022-02-05
2031-02-05
ImmunoGen Inc. IMGN ALTSCHULLER Susan
SVP and CFO
163,798 $7.69 163,798
(Direct)
View
2020-07-20
Option Award
2020-07-22
3:44 pm
2021-07-20
2030-07-20
ImmunoGen Inc. IMGN ALTSCHULLER Susan
SVP and CFO
300,000 $4.74 300,000
(Direct)
View
(A) Indicate amendment filing.